Antiviral effect and application of epigenetic modifying enzyme SETD2

A virus infection and virus infection-related technology, applied in the field of epigenetic modification enzyme SETD2, can solve the problem of unclear role of SETD2 protein, and achieve the effect of preventing and inhibiting virus infection, inhibiting virus infection and improving curative effect.

Active Publication Date: 2017-08-11
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, so far, the role of SETD2 protein in immun

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiviral effect and application of epigenetic modifying enzyme SETD2
  • Antiviral effect and application of epigenetic modifying enzyme SETD2
  • Antiviral effect and application of epigenetic modifying enzyme SETD2

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0107] Example 1: Interference with the expression of SETD2 can promote HBV replication in cells

[0108] HepG2 cells (purchased from ATCC) were cultured in DMEM medium, and the cells were transfected with an HBV expression plasmid based on the framework of pHBV1.3 to simulate the environment of cell infection with HBV. Then the cells were transfected with small interfering RNA for SETD2 (si-SETD2) and a mock control (si-mock) (transfection reagent INTERFERin was purchased from Polyplus).

[0109] Interfering RNA for SETD2 (Si-SETD2) and mimetic control (Si-mimetic) were purchased from Genephama. The sequence of Si-SETD2 is shown in SEQ ID NO: 5 and SEQ ID NO: 6. The sequence is as shown in SEQ ID NO: 7 and SEQ ID NO: 8, adding 2 dT at 3'to make the sequence more stable. The specific sequence is as follows:

[0110] Si-SETD2 sequence:

[0111] 5'-GGUGUAACUUAUGCAUUAATT-3' (Shunyi);

[0112] 5'-UUAAUGCAUAAGUUACACCTT-3' (antisense).

[0113] Si-simulant sequence:

[0114] 5'-UUCUCCGAACGUG...

Example Embodiment

[0120] Example 2: Overexpression of SETD2 inhibits HBsAg secretion in cells

[0121] First, the cDNA of SETD2 (NM_014159.6) was divided into three segments and introduced into the eukaryotic expression vector pcDNA3.1 plasmid, respectively, to construct SETD2-F1, SETD2-F2, and SETD2-F3 expression vectors.

[0122] Wherein, the nucleotide sequence contained in SETD2-F1 is SEQ ID NO: 1 54-2888, encoding human SETD2 protein SEQ ID NO: 2 1-945;

[0123] SETD2-F2 contains the nucleotide sequence of SEQ ID NO:1, positions 2889-5267, encoding human SETD2 protein SEQ ID NO: 2, positions 946-1738, and this truncated body contains the SET domain;

[0124] The nucleotide sequence contained in SETD2-F3 is SEQ ID NO:1 5268-7748, encoding human SETD2 protein SEQ ID NO: 2 1739-2564, and this truncated body contains a WW domain.

[0125] SETD2-F1, SETD2-F2, and SETD2-F3 were transfected into HepG2 cells at a density of 1ng / ml, and pHBV1.3 plasmid was transfected simultaneously. After 48 hours, replace...

Example Embodiment

[0130] Example 3: Overexpression of SETD2 inhibits HBV infection in mouse liver

[0131] Construct SETD2-F2 expression vector (same as Example 2). 20ng SETD2-F2 was injected into mice (8-week-old male SDF grade C57BL6 mice, purchased from Sipper BK) through tail vein high pressure injection, and 10ng pHBV1.3 plasmid was injected with tail vein high pressure at the same time to simulate HBV infection in mice. IFNα (15 mg / kg) was injected intraperitoneally 72 hours later. Dissected after 24 hours, took mouse liver tissue, and used immunofluorescence method to detect the expression of HBV core antigen (HBcAg) on ​​the mouse liver to indicate the HBV infection of the mouse.

[0132] The results of liver HBV infection in mice Figure 4 Shown.

[0133] The results showed that overexpression of SETD2-F2 in mice can inhibit HBV infection in the liver of mice.

[0134] The results indicate that overexpression of SETD2 can inhibit virus infection in vivo.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an antiviral effect and an application of an epigenetic modifying enzyme SETD2. The invention relates to the fields of biotechnology and medicine, and in particular to an anti-virus infection effect and an application of an immuno-regulatory molecule SETD2. Specifically, the invention relates to the SETD2 or an SETD2 coding sequence and an application of an accelerant of the SETD2 in preparing a medicine or a kit for inhibiting virus infection, and further relates to applications of the material in resisting virus infection and treating chronic inflammatory diseases caused by the virus infection, an application method and the corresponding medicine, a pharmaceutical composition or the kit. The SETD2 provided by the invention can be used for preventing and inhibiting the virus infection and enhancing a curative effect of interferon in resisting the virus infection, and the SETD2 has a broad application prospect.

Description

technical field [0001] The present invention relates to the fields of biotechnology and medicine, in particular, an epigenetic modification enzyme SETD2, that is, protein 2 containing SET domain containing 2 (SET domain containing 2, SETD2) is useful in preventing or treating diseases or symptoms related to viral infection. Symptoms, effects, mechanisms of action, implementation methods and uses in controlling damage caused by virus infection. Background technique [0002] Infection, especially viral infection, is a very harmful clinical common disease. At first, people did not fully understand the molecular mechanism of the body's anti-viral infection. With the discovery of a class of cytokines - interferon, the natural immune cells and secondary acquired immune cells produced by the body against viral infection and their effects The molecular biological basis of the disease has gradually been understood. Interferon (IFN) is a general term for a family of cytokines with p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N9/10C12N15/54A61K38/45A61P31/20A61P31/22A61P31/14
CPCA61K38/00C12N9/1007
Inventor 陈坤曹雪涛刘娟
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products